Log in

Reshape Lifesciences SEC Filings & 10K Form (OTCMKTS:RSLS)

$5.25
0.00 (0.00 %)
(As of 04/3/2020 01:14 AM ET)
Today's Range
$5.25
Now: $5.25
$5.25
50-Day Range
$3.70
MA: $6.00
$8.00
52-Week Range
$2.91
Now: $5.25
$28.96
Volume171 shs
Average Volume1,647 shs
Market Capitalization$1.86 million
P/E RatioN/A
Dividend YieldN/A
Beta1.59

SEC Filings

Reshape Lifesciences (OTCMKTS:RSLS) SEC Filings

DateFilerForm TypeView
04/01/2020
3:22 PM
ARMISTICE CAPITAL, LLC (Filed by)
Reshape Lifesciences (Subject)
Form SC 13D/A
03/31/2020
4:21 PM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2020
3:48 PM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2020
4:36 PM
Armistice Capital Master Fund Ltd. (Reporting)
ARMISTICE CAPITAL, LLC (Reporting)
Boyd Steven (Reporting)
Reshape Lifesciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2020
4:24 PM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2020
2:17 PM
CVI Investments, Inc. (Filed by)
Reshape Lifesciences (Subject)
Form SC 13G/A
01/31/2020
4:03 PM
Armistice Capital Master Fund Ltd. (Reporting)
ARMISTICE CAPITAL, LLC (Reporting)
Boyd Steven (Reporting)
Reshape Lifesciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2020
1:28 PM
Reshape Lifesciences (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G/A
12/23/2019
4:25 PM
Armistice Capital Master Fund Ltd. (Reporting)
ARMISTICE CAPITAL, LLC (Reporting)
Boyd Steven (Reporting)
Reshape Lifesciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2019
4:14 PM
Armistice Capital Master Fund Ltd. (Reporting)
ARMISTICE CAPITAL, LLC (Reporting)
Boyd Steven (Reporting)
Reshape Lifesciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2019
4:20 PM
Armistice Capital Master Fund Ltd. (Reporting)
ARMISTICE CAPITAL, LLC (Reporting)
Boyd Steven (Reporting)
Reshape Lifesciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2019
4:34 PM
Armistice Capital Master Fund Ltd. (Reporting)
ARMISTICE CAPITAL, LLC (Reporting)
Boyd Steven (Reporting)
Reshape Lifesciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2019
4:12 PM
Armistice Capital Master Fund Ltd. (Reporting)
ARMISTICE CAPITAL, LLC (Reporting)
Boyd Steven (Reporting)
Reshape Lifesciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2019
4:00 PM
Armistice Capital Master Fund Ltd. (Reporting)
ARMISTICE CAPITAL, LLC (Reporting)
Boyd Steven (Reporting)
Reshape Lifesciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
5:08 PM
Armistice Capital Master Fund Ltd. (Reporting)
ARMISTICE CAPITAL, LLC (Reporting)
Boyd Steven (Reporting)
Reshape Lifesciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
4:16 PM
ARMISTICE CAPITAL, LLC (Filed by)
Reshape Lifesciences (Subject)
Form SC 13D/A
11/14/2019
3:36 PM
Reshape Lifesciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2019
4:08 PM
Armistice Capital Master Fund Ltd. (Reporting)
ARMISTICE CAPITAL, LLC (Reporting)
Boyd Steven (Reporting)
Reshape Lifesciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2019
3:01 PM
Reshape Lifesciences (Issuer)
STANKOVICH THOMAS (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/24/2019
3:11 PM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2019
3:05 PM
Reshape Lifesciences (Filer)
Form DEF 14A
10/01/2019
3:15 PM
BIGGER CAPITAL FUND L P (Filed by)
Reshape Lifesciences (Subject)
Form SC 13G/A
09/30/2019
4:28 PM
ARMISTICE CAPITAL, LLC (Filed by)
Reshape Lifesciences (Subject)
Form SC 13D/A
09/30/2019
5:07 AM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2019
5:53 PM
Armistice Capital Master Fund Ltd. (Reporting)
ARMISTICE CAPITAL, LLC (Reporting)
Boyd Steven (Reporting)
Reshape Lifesciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2019
4:47 PM
Armistice Capital Master Fund Ltd. (Reporting)
ARMISTICE CAPITAL, LLC (Reporting)
Boyd Steven (Reporting)
Reshape Lifesciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2019
4:48 PM
Armistice Capital Master Fund Ltd. (Reporting)
ARMISTICE CAPITAL, LLC (Reporting)
Boyd Steven (Reporting)
Reshape Lifesciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2019
4:19 PM
Armistice Capital Master Fund Ltd. (Reporting)
ARMISTICE CAPITAL, LLC (Reporting)
Boyd Steven (Reporting)
Reshape Lifesciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
1:20 PM
Reshape Lifesciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/15/2019
11:26 AM
Reshape Lifesciences (Filer)
Form NT 10-Q
08/09/2019
4:13 PM
Armistice Capital Master Fund Ltd. (Reporting)
ARMISTICE CAPITAL, LLC (Reporting)
Boyd Steven (Reporting)
Reshape Lifesciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2019
3:22 PM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2019
3:42 PM
Armistice Capital Master Fund Ltd. (Reporting)
ARMISTICE CAPITAL, LLC (Reporting)
Boyd Steven (Reporting)
Reshape Lifesciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2019
3:12 PM
Reshape Lifesciences (Filer)
Form PRE 14A
06/28/2019
2:49 PM
Reshape Lifesciences (Filer)
Form 10-K/A
06/24/2019
3:48 PM
Armistice Capital Master Fund Ltd. (Reporting)
ARMISTICE CAPITAL, LLC (Reporting)
Boyd Steven (Reporting)
Reshape Lifesciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/24/2019
3:13 PM
ARMISTICE CAPITAL, LLC (Filed by)
Reshape Lifesciences (Subject)
Form SC 13D
06/21/2019
4:01 PM
BIGGER CAPITAL FUND L P (Filed by)
Reshape Lifesciences (Subject)
Form SC 13G/A
06/20/2019
3:45 PM
BIGGER CAPITAL FUND L P (Filed by)
Reshape Lifesciences (Subject)
Form SC 13G
06/19/2019
3:42 PM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2019
8:21 PM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2019
4:25 PM
Reshape Lifesciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/16/2019
3:57 PM
Reshape Lifesciences (Filer)
Form NT 10-Q
05/14/2019
3:37 PM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2019
4:17 PM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2019
3:01 PM
Bandy Barton P. (Reporting)
Reshape Lifesciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2019
3:18 PM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2019
3:47 PM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2019
3:16 PM
Reshape Lifesciences (Filer)
Form NT 10-K
03/29/2019
10:53 AM
Reshape Lifesciences (Filer)
Form 424B3
03/12/2019
8:32 AM
Reshape Lifesciences (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
03/04/2019
6:08 AM
Reshape Lifesciences (Filer)
Form 8-K/A
02/14/2019
12:40 PM
CVI Investments, Inc. (Filed by)
Reshape Lifesciences (Subject)
Form SC 13G/A
02/14/2019
8:25 AM
Reshape Lifesciences (Subject)
SVLSF IV, LLC (Filed by)
Form SC 13G/A
02/08/2019
12:40 PM
INTRACOASTAL CAPITAL, LLC (Filed by)
Reshape Lifesciences (Subject)
Form SC 13G/A
02/04/2019
12:35 PM
Reshape Lifesciences (Issuer)
SABBY MANAGEMENT, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2019
9:43 AM
Reshape Lifesciences (Issuer)
SABBY MANAGEMENT, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2019
2:46 PM
Reshape Lifesciences (Issuer)
SABBY MANAGEMENT, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2019
7:30 AM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2019
9:56 AM
Reshape Lifesciences (Issuer)
SABBY MANAGEMENT, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2019
8:39 AM
Reshape Lifesciences (Issuer)
SABBY MANAGEMENT, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2019
2:49 PM
Reshape Lifesciences (Issuer)
SABBY MANAGEMENT, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/17/2019
10:03 AM
Reshape Lifesciences (Issuer)
SABBY MANAGEMENT, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
11:20 AM
Reshape Lifesciences (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G/A
12/28/2018
7:00 AM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2018
3:58 PM
Reshape Lifesciences (Filer)
Form 8-K/A
12/19/2018
7:00 AM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2018
2:38 PM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2018
7:08 AM
Reshape Lifesciences (Filer)
Form 424B5
11/28/2018
7:00 AM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2018
3:06 PM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2018
3:03 PM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2018
3:06 PM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2018
4:21 PM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2018
2:59 PM
Endeavour Medtech Growth L.P. (Filed by)
Reshape Lifesciences (Subject)
Form SC 13G/A
10/09/2018
7:34 AM
Reshape Lifesciences (Filer)
Form DEF 14A
10/03/2018
7:00 AM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2018
7:48 PM
Reshape Lifesciences (Filer)
Form 424B5
09/26/2018
3:05 PM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2018
3:30 PM
Reshape Lifesciences (Filer)
Form PRE 14A
09/20/2018
8:00 AM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2018
3:07 PM
Reshape Lifesciences (Filer)
Form 424B5
09/17/2018
5:04 AM
Reshape Lifesciences (Filer)
Form 424B5
09/14/2018
3:26 PM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2018
3:05 PM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2018
3:06 PM
MINOCHERHOMJEE ARDA PHD (Reporting)
Reshape Lifesciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/28/2018
3:05 PM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2018
3:25 PM
Reshape Lifesciences (Filer)
Form DEF 14A
08/20/2018
4:28 PM
Reshape Lifesciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/15/2018
3:23 PM
Reshape Lifesciences (Filer)
Form NT 10-Q
08/14/2018
3:06 PM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2018
7:00 AM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2018
3:56 PM
Reshape Lifesciences (Filer)
Form PRE 14A
08/09/2018
4:24 PM
Reshape Lifesciences (Filer)
Form 424B5
08/02/2018
3:09 PM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/20/2018
3:57 PM
INTRACOASTAL CAPITAL, LLC (Filed by)
Reshape Lifesciences (Subject)
Form SC 13G
07/13/2018
3:16 AM
Reshape Lifesciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2018
4:09 PM
Anson Funds Management LP (Filed by)
Reshape Lifesciences (Subject)
Form SC 13G
07/12/2018
3:46 PM
Reshape Lifesciences (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G
07/12/2018
7:31 AM
Reshape Lifesciences (Filer)
Form 424B5
This page was last updated on 4/3/2020 by MarketBeat.com Staff

Featured Article: What is a Derivative?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel